Rare Diseases Working Group Should Address CLIA Lab Participation – SACGT
This article was originally published in The Gray Sheet
Executive Summary
The Rare Diseases Working Group of the HHS Secretary's Advisory Committee on Genetic Testing should look at ways to shift testing for rare diseases from research labs to CLIA-certified clinical labs, the committee concluded